42.7 F
New York
Thursday, January 20, 2022

TAG

Esketamine

Pasithea [NASDAQ: KTTA] Announces Addition of Esketamine Nasal Spray to its Clinic Offerings in the U.K

Pasithea Therapeutics Corp. disclosed that its fully-owned subsidiary, Pasithea Clinics, has received authorization to offer Esketamine nasal spray (SPRAVATO) for treatment-resistant depression in...

Latest news